WallStreetZenWallStreetZen

NASDAQ: GNPX
Genprex Inc Earnings & Revenue

Open Broker Account

GNPX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$20.0M
Current Profit Margin
0%

GNPX Return on Equity

Current Company
-51.4%
Current Industry
4.1%
Current Market
25.7%
GNPX's Return on Equity (-51.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GNPX announces earnings.

GNPX Return on Assets

Current Company
-49.1%
Current Industry
3.4%
GNPX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GNPX Return on Capital Employed

Current Company
-61.74%
Current Industry
9.7%
GNPX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GNPX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GNPX$0.00-$19.98M-$20.01MN/AN/A
ONCY$0.00-$18.64M-$18.99MN/AN/A
TCRX$12.34M-$56.69M-$61.29M+107.10%N/A
ANEB$0.00-$6.83M-$6.83MN/AN/A
PASG$0.00-$177.49M-$180.42MN/AN/A

Genprex Earnings & Revenue FAQ

What were GNPX's earnings last quarter?

Genprex (NASDAQ: GNPX) reported Q2 2022 earnings per share (EPS) of -$0.11, up 37.5% year over year. Total Genprex earnings for the quarter were -$5.17 million. In the same quarter last year, Genprex's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Genprex stock.

What was GNPX's earnings growth in the past year?

As of Q3 2022, Genprex's earnings has grown year over year. Genprex's earnings in the past year totalled -$20.01 million.

What was GNPX's revenue last quarter?

Genprex (NASDAQ: GNPX) reported Q2 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Genprex's revenue was $0.00.

What was GNPX's revenue growth in the past year?

As of Q3 2022, Genprex's revenue has grown null year over year. Genprex's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.